Publication: The clinical uses of cytosine arabinoside in retinoblastoma and lymphoma
| dc.contributor.author | K. Tungsubutra | en_US |
| dc.contributor.other | Mahidol University | en_US |
| dc.date.accessioned | 2018-03-22T09:23:51Z | |
| dc.date.available | 2018-03-22T09:23:51Z | |
| dc.date.issued | 1973-12-01 | en_US |
| dc.description.abstract | A clinical trial of cytosine arabinoside was made with 16 late cases of lymphoma and 4 cases of stage 4 retinoblastoma. Most of the cases selected for this trial were those who had already received other forms of conventional treatment and would not further respond to it. A few of these cases responded to this drug quite excellently with a long remission period and reasonably long survival period. The untoward effect of this drug employed in a dosage described above is negligible. This encourages the authors to use this drug in combination with others in the ''cocktail'' programme in earlier cases of lymphoma. | en_US |
| dc.identifier.citation | Journal of the Medical Association of Thailand. Vol.56, No.9 (1973), 514-518 | en_US |
| dc.identifier.issn | 01252208 | en_US |
| dc.identifier.other | 2-s2.0-0015818949 | en_US |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/123456789/10182 | |
| dc.rights | Mahidol University | en_US |
| dc.rights.holder | SCOPUS | en_US |
| dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0015818949&origin=inward | en_US |
| dc.subject | Medicine | en_US |
| dc.title | The clinical uses of cytosine arabinoside in retinoblastoma and lymphoma | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0015818949&origin=inward | en_US |